NEW YORK (Reuters Health) - Nearly every prescription written to treat Parkinson's psychosis -- a common psychiatric side effect of Parkinson's disease -- is for medications that have not been shown ...
Two recent studies indicate that Nuplazid (pimavanserin) is safe and tolerated well in older or frail adults who experience psychosis linked to Parkinson’s disease. The drug is the only one currently ...
Clinical diagnosis of Parkinson's disease (PD) could be performed in the presence of motor symptoms such as resting tremor, rigidity, akinesia, bradykinesia and postural instability. Nonmotor symptoms ...
Medical management of PDP attempts to decrease psychotic symptoms without impeding motor symptom control. The first step in treatment involves reducing the dose of antiparkinson drugs, starting with ...
(AP) Shares of Acadia Pharmaceuticals Inc. more than doubled to their highest price in more than three years Tuesday after the company said its drug pimavanserin reduced psychosis in patients with ...
Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...
-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions SAN ...
Reynolds says he hopes to raise awareness of some of the early signs and symptoms of the disease, including less common psychological and cognitive problems. Reynolds’ father experienced ...
PDP is a clinical diagnosis; no laboratory test or imaging method can definitively diagnose PDP or its symptoms. 1 Diagnostic criteria, described by the National Institute of Neurological Disorders ...